# GBM AGILE (NCT03970447)

> A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03970447
- Phase: PHASE2, PHASE3
- Status: RECRUITING
- Sponsor: Global Coalition for Adaptive Research
- Conditions: Glioblastoma
- Interventions: Temozolomide; Lomustine; Regorafenib; Radiation; Paxalisib; VAL-083; VT1021; Troriluzole; ADI-PEG 20; AZD1390; Tinostamustine
- Enrollment: 2250
- Primary outcome: Overall Survival (OS)

## Commentary we found

- YouTube: 14
- Podcasts: 3
- X threads: 3

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=gbm-agile-nct03970447

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03970447", "email": "<work email>"}; the inbox owner confirms by the emailed link.